We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Advanced Micro Devices, Inc. (AMD) - free report >>
NVIDIA Corporation (NVDA) - free report >>
Broadcom Inc. (AVGO) - free report >>
iShares Biotechnology ETF (IBB) - free report >>
iShares Semiconductor ETF (SOXX) - free report >>
iShares Genomics Immunology and Healthcare ETF (IDNA) - free report >>
Image: Bigstock
Top Thematic ETF Ideas for 2024: AI & More
In this episode of ETF Spotlight, I speak with Jay Jacobs, U.S. Head of Thematics & Active Equity ETFs at BlackRock, about the 2024 thematic investing outlook.
Mega-cap stocks surged last year, thanks largely to the AI Bonanza. With AI adoption and spending expected to expand this year, new avenues for business growth will open up for tech companies beyond the Magnificent Seven.
We’ll see more enterprise spending on AI due to increasing use cases and significant cost savings. According to BlackRock, investors should focus broadly on the AI value chain and specifically on semiconductors.
NVIDIA (NVDA - Free Report) , AMD (AMD - Free Report) and Broadcom (AVGO - Free Report) are the top holdings in the iShares PHLX Semiconductor ETF (SOXX - Free Report) . The iShares Robotics and Artificial Intelligence Multisector ETF includes many small- and mid-cap companies that are attractively valued compared to mega caps.
Biotech companies struggled last year as interest rates surged. In addition to attractive valuations, companies specializing in genomics and neuroscience are poised to benefit from AI-driven medical innovation.
The iShares Biotechnology ETF (IBB - Free Report) and the iShares Genomics Immunology and Healthcare ETF (IDNA - Free Report) are worth considering.
Many American companies are now focusing on nearshoring, friend-shoring, and reshoring to make their supply chains safer and more reliable. India and Mexico are among the biggest beneficiaries of this trend.
Tune in to the podcast to learn more.
Make sure to be on the lookout for the next edition of the ETF Spotlight and remember to subscribe! If you have any comments or questions, please email podcast@zacks.com.